Soft Tissue Sarcoma, Version 2.2022

被引：171

作者：

von Mehren, Margaret ^{[1
]}

Kane, John M., III ^{[2
]}

Agulnik, Mark ^{[3
]}

Bui, Marilyn M. ^{[4
]}

Carr-Ascher, Janai ^{[5
]}

Choy, Edwin ^{[6
]}

Connelly, Mary ^{[7
]}

Dry, Sarah ^{[8
]}

Ganjoo, Kristen N. ^{[9
]}

Gonzalez, Ricardo J. ^{[4
]}

Holder, Ashley ^{[10
]}

Homsi, Jade ^{[11
]}

Keedy, Vicki ^{[12
]}

Kelly, Ciara M. ^{[13
]}

Kim, Edward ^{[14
]}

Liebner, David

McCarter, Martin ^{[15
]}

V. McGarry, Sean ^{[16
]}

Mesko, Nathan W. ^{[17
,18
]}

Meyer, Christian ^{[19
]}

Pappo, Alberto S. ^{[20
]}

Parkes, Amanda M. ^{[21
]}

Petersen, Ivy A. ^{[22
]}

Pollack, Seth M. ^{[23
]}

Poppe, Matthew ^{[24
]}

Riedel, Richard F. ^{[25
]}

Schuetze, Scott ^{[26
]}

Shabason, Jacob ^{[27
]}

Sicklick, Jason K. ^{[28
]}

Spraker, Matthew B. ^{[29
,30
]}

Zimel, Melissa ^{[31
]}

Hang, Lisa E. ^{[32
]}

Sundar, Hema ^{[32
]}

Bergman, Mary Anne ^{[32
]}

机构：

[1] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[2] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA

[3] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA

[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[5] UC Davis Comprehens Canc Ctr, Sacramento, CA USA

[6] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

[7] Ohio State Univ, Comprehens Canc Ctr, James Canc Hosp & Solove Res Inst, Columbus, OH 43210 USA

[8] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA

[9] Stanford Canc Inst, Stanford, CA USA

[10] UAB, ONeal Comprehens Canc Ctr, Birmingham, AL USA

[11] UT Southwestern Simmons Comprehens Canc Ctr, Dallas, TX USA

[12] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[13] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[14] Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA USA

[15] Univ Colorado, Canc Ctr, Boulder, CO 80309 USA

[16] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[17] Univ Hosp, Case Comprehens Canc Ctr, Seidman Canc Ctr, Coimbatore, Tamil Nadu, India

[18] Cleveland Clin Taussig Canc Inst, Cleveland, OH USA

[19] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[20] Univ Tennessee, Hlth Sci Ctr, St Jude Res Hosp, Knoxville, TN 37996 USA

[21] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[22] Mayo Clin, Canc Ctr, Rochester, MN USA

[23] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[24] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[25] Duke Canc Inst, Durham, NC USA

[26] Univ Michigan, Roger Canc Ctr, Ann Arbor, MI 48109 USA

[27] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[28] UC San Diego Moores Canc Ctr, San Diego, CA USA

[29] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[30] Univ Washington, Sch Med, Seattle, WA 98195 USA

[31] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[32] Natl Comprehens Canc Network, Durham, NC USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2022年 / 20卷 / 07期

关键词：

RANDOMIZED PHASE-II; PREOPERATIVE RADIATION-THERAPY; DOXORUBICIN PLUS IFOSFAMIDE; ELECTRON-BEAM RADIOTHERAPY; HIGH-RISK EXTREMITY; NEOADJUVANT CHEMOTHERAPY; EUROPEAN-ORGANIZATION; RETROPERITONEAL SARCOMA; ADJUVANT CHEMOTHERAPY; 1ST-LINE TREATMENT;

D O I：

10.6004/jnccn.2022.0035

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Soft tissue sarcomas (STS) are rare malignancies of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic char-acteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of pa-tients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Soft Tissue Sarcoma provide recommendations for the diagnosis, eval-uation, and treatment of extremity/superficial trunk/head and neck STS, as well as retroperitoneal/intra-abdominal STS, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guide-lines discusses general principles for the diagnosis and treatment of retroperitoneal/intra-abdominal STS, outlines treatment recom-mendations, and reviews the evidence to support the guidelines recommendations. J Natl Compr Canc Netw 2022;20(7):815???833 doi: 10.6004/jnccn.2022.0035

引用

页码：815 / 833

页数：19

共 139 条

[21] ADJUVANT CYVADIC CHEMOTHERAPY FOR ADULT SOFT-TISSUE SARCOMA-REDUCED LOCAL RECURRENCE BUT NO IMPROVEMENT IN SURVIVAL - A STUDY OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER SOFT-TISSUE AND BONE SARCOMA GROUP
BRAMWELL, V
ROUESSE, J
STEWARD, W
SANTORO, A
SCHRAFFORDTKOOPS, H
BUESA, J
RUKA, W
PRIARIO, J
WAGENER, T
BURGERS, M
VANUNNIK, J
CONTESSO, G
THOMAS, D
VANGLABBEKE, M
MARKHAM, D
PINEDO, H
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) : 1137 - 1149
[22] Bramwell VH, 2003, Cochrane Database Syst Rev, DOI DOI 10.1002/14651858.CD003293
[23] A Contemporary Large Single-Institution Evaluation of Resected Retroperitoneal Sarcoma
Bremjit, Prashoban J.
Jones, Robin L.
Chai, Xiaoyu
Kane, Gabrielle
Rodler, Eve T.
Loggers, Elizabeth T.
Pollack, Seth M.
Pillarisetty, Venu G.
Mann, Gary N.
[J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (07) : 2150 - 2158
[24] HIGH-DOSE DTIC IN ADVANCED SOFT-TISSUE SARCOMAS IN THE ADULT - A PHASE II STUDY OF THE EORTC SOFT-TISSUE AND BONE-SARCOMA-GROUP
BUESA, JM
MOURIDSEN, HT
VANOOSTEROM, AT
VERWEIJ, J
WAGENER, T
STEWARD, W
POVEDA, A
VESTLEV, PM
THOMAS, D
SYLVESTER, R
[J]. ANNALS OF ONCOLOGY, 1991, 2 (04) : 307 - 309
[25] Multicenter phase II study of pembrolizumab (P) in advanced soft tissue (STS) and bone sarcomas (BS): Final results of SARC028 and biomarker analyses
Burgess, Melissa Amber
Bolejack, Vanessa
Van Tine, Brian Andrew
Schuetze, Scott
Hu, James
D'Angelo, Sandra P.
Attia, Steven
Priebat, Dennis A.
Okuno, Scott H.
Riedel, Richard F.
Davis, Lara Emily
Mowa, Sujana
Reed, Damon R.
Butterfield, Lisa Helene
Roszik, Jason
Reinke, Denise K.
Baker, Laurence H.
Maki, Robert G.
Patel, Shreyaskumar
Tawbi, Hussein Abdul-Hassan
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[26] Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials
Cesne, A. L.
Judson, I.
Maki, R.
Grosso, F.
Schuetze, S.
Mehren, M. V.
Chawla, S. P.
Demetri, G. D.
Nieto, A.
Tanovic, A.
Blay, J-Y
[J]. BRITISH JOURNAL OF CANCER, 2013, 109 (07) : 1717 - 1724
[27] Chowdhary M, 2021, LANCET ONCOL, V22, pE2, DOI 10.1016/S1470-2045(20)30626-4
[28] Clasby R, 1997, BRIT J SURG, V84, P1692, DOI 10.1002/bjs.1800841213
[29] Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapya European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072)
Coens, Corneel
van der Graaf, Winette T. A.
Blay, Jean-Yves
Chawla, Sant P.
Judson, Ian
Sanfilippo, Roberta
Manson, Stephanie C.
Hodge, Rachel A.
Marreaud, Sandrine
Prins, Judith B.
Lugowska, Iwona
Litiere, Saskia
Bottomley, Andrew
[J]. CANCER, 2015, 121 (17) : 2933 - 2941
[30] Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: Chemotherapy-associated outcomes
Cormier, JN
Huang, XL
Xing, Y
Thall, PF
Wang, XM
Benjamin, RS
Pollock, RE
Antonescu, CR
Maki, RG
Brennan, MF
Pisters, PWT
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (22) : 4567 - 4574

← 1 2 3 4 5 6 7 8 9 10 →